Literature DB >> 1937814

Relation between structure and immunologic properties of the Vi capsular polysaccharide.

S C Szu1, X R Li, A L Stone, J B Robbins.   

Abstract

The Vi capsular polysaccharide of Salmonella typhi is a linear homopolymer of poly-alpha(1----4)GalNAcp variably O acetylated at the C-3 position. Serum antibodies elicited by this antigen confer protective immunity against typhoid fever. The relation between the immunologic properties and structure of Vi was investigated by carboxyl reduction, O deacetylation, and acid hydrolysis. The immunogenicity of Vi was closely related to its degree of O acetylation. Partial O deacetylation slightly increased immunogenicity; complete O deacetylation eliminated the immunogenicity of Vi. O-deacetylated Vi, however, still reacted with antisera prepared by injection of whole bacteria. Carboxyl reduction, in contrast, had a comparatively slight effect upon both the immunogenicity and antigenicity of Vi. Retention levels of antigenicity after acid treatment were greater for both the native and carboxyl-reduced Vi than for the O-deacetylated product. The Courtauld-Koltun space-filling model of a pentamer of Vi demonstrated that the bulky nonpolar O-acetyls, which protrude in rows on both sides, make up most of the surface. The carboxyls are less exposed and are partially shielded by the O-acetyls. The molecular model thus provides an explantation for the dominant role of the O-acetyls, as well as the lesser effect of carboxyl reduction, upon the immunologic properties of Vi.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937814      PMCID: PMC259077          DOI: 10.1128/iai.59.12.4555-4561.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The effect of variation in molecular weight on the antigenicity of dextran in man.

Authors:  E A KABAT; A E BEZER
Journal:  Arch Biochem Biophys       Date:  1958-12       Impact factor: 4.013

2.  Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance.

Authors:  A K Bhattacharjee; H J Jennings; C P Kenny; A Martin; I C Smith
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

3.  Identification of a subgroup antigen on the Neisseria meningitidis group C capsular polysaccharide.

Authors:  M A Apicella
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Leucocyte values of alpha-L-iduronidase activity in mucopolysaccharidosis I.

Authors:  T E Kelly; H A Taylor
Journal:  J Med Genet       Date:  1976-04       Impact factor: 6.318

5.  Quantitative determination of pneumococcal capsular polysaccharides in the polyvalent vaccine. I. Standardization of an immunoelectrophoretic method.

Authors:  C J Lee; S J Pearson; J B Robbins
Journal:  J Biol Stand       Date:  1980

6.  Appraisal of typhoid vaccine in experimentally infected human subjects.

Authors:  R B Hornick; T E Woodward
Journal:  Trans Am Clin Climatol Assoc       Date:  1967

7.  Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants.

Authors:  B Szewczyk; A Taylor
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

8.  Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V.

Authors:  S Szu; C J Lee; D Carlo; J Henrichsen
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Identification of Salmonella typhi in faecal specimens by an antiserum-agar method.

Authors:  C M Nolan; E A LaBorde; R T Howell; J B Robbins
Journal:  J Med Microbiol       Date:  1980-05       Impact factor: 2.472

10.  Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.

Authors:  F Orskov; I Orskov; A Sutton; R Schneerson; W Lin; W Egan; G E Hoff; J B Robbins
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  45 in total

1.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

2.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis.

Authors:  Ho Jun Lee; Bojana Rakić; Michel Gilbert; Warren W Wakarchuk; Stephen G Withers; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2009-06-12       Impact factor: 5.157

4.  A scalable method for O-antigen purification applied to various Salmonella serovars.

Authors:  F Micoli; S Rondini; M Gavini; I Pisoni; L Lanzilao; A M Colucci; C Giannelli; F Pippi; L Sollai; V Pinto; F Berti; C A MacLennan; L B Martin; A Saul
Journal:  Anal Biochem       Date:  2012-11-07       Impact factor: 3.365

5.  Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution.

Authors:  Juan J Calix; Ron Dagan; Stephen I Pelton; Nurith Porat; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

6.  Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Authors:  Michael Wetter; Michael Kowarik; Michael Steffen; Paula Carranza; Giampietro Corradin; Michael Wacker
Journal:  Glycoconj J       Date:  2012-10-06       Impact factor: 2.916

7.  In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate.

Authors:  Thomas J Griffin; Ann Thanawastien; Robert T Cartee; John J Mekalanos; Kevin P Killeen
Journal:  Hum Vaccin Immunother       Date:  2019-05-28       Impact factor: 3.452

8.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

9.  Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi.

Authors:  J Liao; K G Nickerson; S Bystricky; J B Robbins; R Schneerson; S C Szu; E A Kabat
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation.

Authors:  Pia S Pannaraj; Morven S Edwards; Kristen T Ewing; Amanda L Lewis; Marcia A Rench; Carol J Baker
Journal:  Vaccine       Date:  2009-05-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.